Daily Anesthesiology Research Analysis
Analyzed 6 papers and selected 3 impactful papers.
Summary
Today’s leading anesthesiology research highlights a prospective ultrasound-based predictor of spinal anesthesia-induced hypotension, a randomized trial of intraoperative transcutaneous electrical acupoint stimulation for post-cesarean pain, and a large real-world cohort evaluating sugammadex in patients with chronic obstructive pulmonary disease. Together, these studies address perioperative risk prediction, non-opioid analgesia, and postoperative pulmonary outcomes while illustrating the need for external validation and cautious interpretation of observational associations.
Research Themes
- Perioperative hemodynamic risk prediction
- Non-pharmacological postoperative analgesia
- Postoperative pulmonary complications in high-risk patients
Selected Articles
1. EXPRESS: Preoperative Corrected Carotid Flow Time Is Associated With Spinal Anesthesia-Induced Hypotension in Hypertensive Patients: A Prospective Observational Study.
In this single-center prospective study of 110 hypertensive adults, spinal anesthesia-induced hypotension occurred in 54 patients (49.1%). Preoperative corrected carotid flow time was independently associated with hypotension, and its addition to age, baseline systolic blood pressure, and beta-blocker use increased the area under the curve from 0.572 to 0.866.
Impact: The study identifies a noninvasive, physiologically interpretable ultrasound marker that may enable individualized prevention of hypotension during spinal anesthesia. Its strong incremental discrimination is clinically promising, although the single-center, cohort-derived threshold requires external validation.
Clinical Implications: Preoperative carotid Doppler assessment could help identify hypertensive patients at increased risk of spinal anesthesia-induced hypotension and support targeted fluid, vasopressor, or monitoring strategies. The 358.5-ms threshold should not yet be adopted as a stand-alone clinical decision rule.
Key Findings
- Spinal anesthesia-induced hypotension occurred in 54 of 110 patients (49.1%).
- Corrected carotid flow time was shorter in patients with hypotension than in those without hypotension (326.5 versus 437.3 ms; P<0.001).
- Corrected carotid flow time alone had an AUC of 0.854, and adding it to a clinical model increased the AUC to 0.866.
Methodological Strengths
- Prospective measurement of multiple preoperative ultrasound variables with standardized postoperative hemodynamic monitoring.
- Multivariable analysis and comparison of discriminative performance quantified the incremental value of corrected carotid flow time.
Limitations
- The study was single-center and observational, leaving potential residual confounding and limited generalizability.
- The proposed cutoff was derived from the same cohort and requires prospective external validation before implementation.
Future Directions: Multicenter validation should assess reproducibility across operators, devices, surgical populations, and antihypertensive regimens. Future interventional trials should determine whether CCFT-guided fluid or vasopressor management reduces hypotension and related complications.
BACKGROUND: Spinal anesthesia-induced hypotension (SAIH) is common in hypertensive patients, yet reliable preoperative markers remain limited. Corrected carotid flow time (CCFT) is a Doppler-derived index influenced by preload and ventricular ejection timing, but its association with SAIH in this population has not been established. OBJECTIVE: To evaluate whether preoperative CCFT is independently associated with SAIH in hypertensive patients undergoing spinal anesthesia. DESIGN: Single-center prospective observational study. SETTING: University hospital, operating room. PATIENTS: 110 hypertensive adults scheduled for lower abdominal or lower extremity surgery under spinal anesthesia.
2. Intraoperative Transcutaneous Electrical Acupoint Stimulation Attenuates Postoperative Mechanical Pain Sensitization and Visceral Pain After Elective Cesarean Delivery: A Randomized Controlled Trial.
In this randomized trial, 79 analyzed participants undergoing elective cesarean delivery received continuous intraoperative transcutaneous electrical acupoint stimulation or sham stimulation. Stimulation increased the postoperative pressure pain threshold ratio, reduced uterine cramping pain and severe visceral pain, and shortened hospital stay, but did not significantly reduce incisional pain or cumulative analgesic consumption.
Impact: This trial provides controlled evidence that a low-risk, non-pharmacological intraoperative intervention can modify postoperative pain sensitization and visceral pain. The selective effect on visceral rather than incisional pain also generates a clinically relevant mechanistic hypothesis.
Clinical Implications: Transcutaneous electrical acupoint stimulation may be considered as an adjunct to multimodal post-cesarean analgesia, particularly for visceral or uterine cramping pain. Confirmation in larger, blinded, multicenter trials is needed before routine adoption.
Key Findings
- The 30-minute postoperative-to-baseline pressure pain threshold ratio was higher with stimulation than with sham treatment (mean difference 0.208; 95% CI 0.057-0.359; P=0.008).
- Severe visceral pain occurred in 15.38% of the stimulation group versus 40.00% of controls; adjusted OR 0.26 (95% CI 0.08-0.73; P=0.005).
- Hospital stay was shorter with stimulation, while incisional pain and cumulative analgesic consumption did not differ significantly.
Methodological Strengths
- Randomized sham-controlled design with a prespecified primary mechanistic outcome.
- Assessment included pressure pain threshold, pain tolerance, clinical pain scores, analgesic use, and adverse events.
Limitations
- The analyzed sample was small, with 79 participants, limiting precision and generalizability.
- Secondary outcomes were not adjusted for multiple comparisons and should be considered exploratory; effects on opioid consumption were not demonstrated.
Future Directions: Larger multicenter trials should use rigorous participant and assessor blinding, standardized background analgesia, longer follow-up, and multiplicity-controlled secondary outcomes. Mechanistic studies should clarify why stimulation preferentially affects visceral rather than incisional pain.
INTRODUCTION: Postoperative pain after cesarean delivery remains prevalent despite multimodal analgesia. This randomized controlled trial evaluated whether continuous intraoperative transcutaneous electrical acupoint stimulation (TEAS) attenuates postoperative mechanical pain sensitization and improves clinical pain outcomes. METHODS: Eighty parturients undergoing elective cesarean delivery under neuraxial anesthesia were randomized 1:1 to TEAS (PC6 and LI4; from 30 min before incision until 10 min after closure) or sham control. The primary outcome was mechanical pain sensitization, quantified by the 30-min postoperative-to-baseline pressure pain threshold (PPT) ratio.
3. Impact of sugammadex on postoperative pneumonia and COPD exacerbations in COPD patients: A retrospective cohort study.
Using propensity-score matching in the TriNetX database, 34,031 COPD patients per group were compared after elective general anesthesia. Sugammadex was associated with lower 30-day postoperative pneumonia, particularly among older patients and at academic centers, but it was not associated with fewer COPD exacerbations or lower mortality and was associated with more ICU admissions.
Impact: The very large cohort addresses an important perioperative safety question in a vulnerable pulmonary population and identifies a clinically measurable pneumonia signal. The discordant ICU finding and absence of benefit for exacerbations or mortality appropriately temper causal conclusions.
Clinical Implications: Sugammadex may be a reasonable reversal option for selected COPD patients at high risk of postoperative pneumonia, but this study does not establish that it prevents pulmonary complications. Clinicians should not infer mortality or COPD-exacerbation benefit, and the possible ICU-admission signal requires further investigation.
Key Findings
- After matching, 34,031 patients were analyzed in each treatment group.
- Sugammadex was associated with lower 30-day pneumonia incidence than neostigmine (1.8% versus 2.1%; HR 0.84; P=0.002).
- COPD exacerbations and mortality did not differ significantly, while ICU admission was higher with sugammadex (HR 1.22; P<0.001).
Methodological Strengths
- Large multicenter real-world database with 1:1 propensity-score matching and multiple clinically relevant outcomes.
- Sensitivity and subgroup analyses examined effect modification by academic setting and age.
Limitations
- Retrospective database analysis is vulnerable to residual confounding, treatment-selection bias, coding error, and incomplete clinical detail.
- The pneumonia association disappeared during 30- to 90-day follow-up, and the increased ICU admission may reflect selection bias rather than a causal effect.
Future Directions: Prospective comparative effectiveness studies should incorporate neuromuscular monitoring, residual neuromuscular blockade, extubation criteria, baseline pulmonary function, and detailed postoperative respiratory management. A pragmatic randomized trial in high-risk COPD patients could determine whether sugammadex causally reduces pneumonia.
Patients with chronic obstructive pulmonary disease (COPD) have an elevated risk of postoperative pulmonary complications. This study investigated whether sugammadex use was associated with a reduced risk of postoperative pneumonia and COPD exacerbations compared to neostigmine in this high-risk population. This retrospective cohort study utilized the TriNetX database to identify COPD patients undergoing elective surgery under general anesthesia between 2015 and 2024. Patients receiving rocuronium with sugammadex reversal were compared to those receiving neostigmine reversal using 1:1 propensity score matching. The primary outcome was 30-day postoperative pneumonia.